-
Mashup Score: 3
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 3
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 3
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 3
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 2
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 3
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 8
Investigation evaluates safety of single and multiple intravitreal injections.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0
Background/aims The aim of this study was to develop a risk model for intraoperative complication (IC) during cataract surgery, defined as posterior capsule rupture and/or zonular dehiscence, and to include previous intravitreal therapy (pIVT) in the model. Methods This retrospective register-based study covered patients reported to the Swedish National Cataract Register (SNCR) between 1 January…
Source: British Journal of OphthalmologyCategories: Latest Headlines, OphthalmologyTweet-
Swedish study of over 900,000 patients undergoing #cataract surgery, showed having a previous #intravitreal injection was linked to an increased risk of intraoperative complications including posterior capsule rupture and/or zonular dehiscence. Read more: https://t.co/tq2N2oywVw https://t.co/RbxXbqJAsA
-
Phase 1 trial shows NGM621 for geographic atrophy is well tolerated by study participants — with no serious adverse effects, according to Charles C. Wykoff, MD, PhD (@TXRetinaSurgeon). https://t.co/KCyynolAxo @NGMBio #intravitreal #Ophthalmology #retinal @RetinaOfTexas https://t.co/GMTQnX7Vo1